SCISP
Sickle Cell & Thalassaemia Support Project
Annual Report
2024-2025
00m
CON
Company No: 3575079
Charity No: 1077687
sctsp.org.uk
f

Chairman's Remarks
I want to take this opportunity to reflect on the achievements and challenges faced over the past financial year.
We have successfully continued to provide services to meet the needs of the community, with an emphasis on
outreach work, organising activities, and engaging directly with families. Despite the increasing challenges in the
voluntary sector due to funding constraints, we have made continued difference to affected families and
individuals. Collaboration with service providers at district and regional levels has been a key strategy to offer
more structured and integrated services. I want express my gratitude and appreciation to all supporters for their
valuable contributions. - Clarence Crosdale
About Us
The Sickle Cell & Thalassaemia Support Project (SCTSP) is a community organisation supporting individuals and
families living with Sickle cell and Thalassaemia blood disorders across Wolverhampton, Walsall, Dudley and
surrounding areas.
We aim to:
• Provide specialist information, advice and practical support
• Deliver wellbeing and community activities that improve quality of life
• Raise awareness among health professionals and the wider public
• Empower families and young people to thrive despite the challenges of long-term conditions
Our work includes direct one-to-one counselling as part of the NHS Sickle Cell & Thalassaemia Screening
Programme, group activities and wider health and wellbeing programmes.
Our Impact
From April 2024 to March 2025, we received and processed 717 unusual blood results.
Antenatal
Neonatal
Wolverhampton
202
134
Walsall
158
105
Dudley
118
To learn more about this process, please visit https://www.nhs.uk/pregnancy and search for screening for sickle.
We have supported service users with their health plans and we have worked with schools to provide a new or
reviewed care plan for children. We have also supported many affected adults, children and their families with
their wellbeing through multiple activities and events.
Number of Sickle Cell & Thalassaemia Clients:
165 Adults, 173 Children
Areas of support:
Wolverhampton, Walsall, Dudley and the surrounding areas.
Finances
NHS Contracts (70.6%)
Income Breakdown 2024-25
Investments (10.2%)
O
Donations & Other (19.2%)
Expenditure Breakdown 2024-25
General Overheads (11.4%)
O
Premises (5.9%)

Young Person & Family Engagement
This year, we were proud to deliver a wide range of opportunities for young people to learn, connect and thrive.
Our annual Sports Day featured football, archery and badminton, while our VR Workshops gave young people a
chance to explore the world virtually and reflect on their experiences of NHS care.
In February 2025 many families came together at our Move, Stretch & Dance Workshop, enjoying a day of
movement and fun. Families also benefitted from special events such as the Collins Aerospace Family Fun Day,
where children enjoyed rides, activities and face painting.
"The kids had an absolute blast playing with other kids present and they can't stop talking about how much fun
they had. Thank you all for having us."- Parent in Walsall
Community Support & Keeping Warm
In February 2025, we delivered the Winter Warm Project in partnership with National Grid and Act On Energy,
distributing warm packs, conducting home visits and sharing practical advice on energy efficiency.
At Christmas, we ran donation events in Wolverhampton and Walsall, distributing food, toiletries and children's
clothing with the help of volunteers from Collins Aerospace. Families also received baby clothes, toys and home
essentials throughout the winter to help them stay warm and well.
"In general these items have not only met our immediate needs, but also brought a sense of security and hope.
We are grateful and we thank you all for putting smiles on our faces."- Parent in Wolverhampton

Health & Wellbeing Support
In November 2024, we launched our Wellbeing Support Programme, offering families free support directly from the
project.
This included:
• Support to live a healthier lifestyle through nutrition, physical activity, mental wellbeing and sleep
• Support for adults and young people to understand how to manage their emotions
• Emotional regulation and coping strategies for children and young people
Alongside this, our free massage service proved to be very popular with adults affected by Sickle cell, This was
introduced following feedback at our AGM. Many patients found the sessions to be a great relief from pain and
stress. Due to the popularity, we extended this programme through to March 2025.
"I found the massage session extremely beneficial, especially for my stress levels, relaxation and also took away
the awful headache, shoulder and neck pain/tension that I woke up with this morning"- Adult in Wolverhampton
In December 2024, parents caring for children with Sickle Cell and Thalassaemia also benefitted from a Stress and
Relaxation Workshop, where they were able to learn practical self-care tools and strategies.
Shaping Healthcare Services
We were commissioned by NHS England to carry out research into patient experiences of unplanned and
emergency care. Through drop-in sessions, surveys and group events, we gathered meaningful insights that will
help shape better care pathways nationally.
In addition, opportunities were created for young people to have a direct influence on the future of healthcare
through the planned Youth Forum at The Royal Wolverhampton NHS Trust.
Alas
"NOT ORDINARY PEOR
Awareness & Advocacy
In September 2024, we marked National Sickle Cell Awareness Month with educational talks, workplace training
and a feature on #The VoiceBox radio show.
During Black History Month in October 2024, we were proud to take part in events, including guest speaking at
Holy Trinity Church and hosting our own event in Dudley, where families also received free Winter Warm Packs as
part of the National Grid- Staying Warm This Winter project.
Our specialist nurses and community counsellors represented the project in hospitals and community spaces
throughout the year, including raising awareness at Walsall Manor Hospital. At the same time, we continued to
engage with NHS England and wider research partners.

Partnerships & Fundraising
Our work this year was strengthened by the generous contributions and involvement of our partners. Collins
Aerospace supported us in numerous ways, inviting young people to their Olympics event, hosting STEM workshops,
family days, and raising £1, 361 through the Tough Mudder Challenge.
West Bromwich Building Society donated £600 towards our hardship fund and local fundraising during Black
History Month also provided additional resources for families in need.
National Grid also supported us to keep families warm and healthy through workshops and winter warm packs.
The aim of this was to provide advice and essential items to keep homes warm and reduce the cost of energy bills.
STEP
REDEFINE
ACTUATION
Pay.
I CELL AND
SSAEMIA PROTECT
€ 1.36100
Signed EMERSCE ERd
Acknowledgements
We extend our gratitude to our staff, board members, volunteers, funders and community partners for their
commitment and support. Most importantly, we thank the families we support. Your strength, resilience and
feedback continue to inspire our work and shape everything we do.
Our Supporters
3n Collins Aerospace
nationalgrid
Walsall Healthcare NHS
NHS Trust
Act
# On
Energy
INHS
Dudley Integrated
Health and Care
NHS Trust
Paycane
THE
NEW
BLACK
FILM COLLECTIVE
NHS
Black Country
Integrated Care Board

COMPANY REGISTERED NUMBER: 03575079 (England and Wales)
CHARITY REGISTERED NUMBER: 1077687
SICKLE CELL AND THALASSAEMIA SUPPORT
PROJECT (WOLVERHAMPTON)
REPORT OF THE DIRECTORS AND
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
Company Information
Report of the Directors and Trustees
Statement of Trustees' responsibilities
Independent examiner's report
Statement of financial activities
Balance sheet
Notes to the financial statements
Page
1
2
4
5

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MARCH 2025
DIRECTORS/TRUSTEES:
SECRETARY:
REGISTERED OFFICE:
C R Crosdale
D Mcintosh
A Mcintos!
Or D Kalri
L Bell
LT Mooruth
DC Smith
A A Ezomon
S Herian
Paycare House
1st Floor
George Street
Wolverhampton
WV2 4DX
03575079 (England and Wales)
REGISTERED NUMBER:
REGISTERED CHARITY
NUMBER:
INDEPENDENT EXAMINER:
BANKERS:
SOLICITORS:
1077687
Neil Harris FCA BSc (Hons)
Cygnet Accounting Limited
37 Rossell Driv
Nottingham, NG9 TEC
Lloyds Bank Plc
37 Queen Square
Wolverhampton
WV1 1TL
Wall James Chappell
15-23 Hagley Road
Stourbridge
DY8 1QW
Page 1

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2025
The directors, who are also trustees of the charity, present their report with the financial statements of the
company for the year ended 31st March 2025. The directors have adopted the provisions of the Statement of
Recommended Practice (SORP) "Accounting and Reporting by Charities" (FRS 102) in preparing the annual
report and financial statements.
PRINCIPAL ACTIVITIES
The principal charitable activities of the company in the year under review were those to provide relief of
poverty, sickness and distress, and enhancement of life, to those affected by the disorders Sickle Cell Disease
and Thalassaemia, living within the West Midlands and surrounding areas. Those so affected are
predominantly from African, Caribbean, Mediterranean and Asian communities. In 2016 the charity had
expanded its activities to include working with families with complex and multiple needs, in order to promote,
strengthen and improve their life chances.
DIRECTORS AND TRUSTEES
The directors and trustees during the year under review were:
C R Crosdale
D Mcintosh
DA Mcintosh
Dr D Kalra
L Bell
L T Mooruth
D C Smith
A A Ezomon
COMPANY STATUS
The company is limited by guarantee and is a registered charity (Registered No 1077687). This report has
been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to
small companies.
OBJECTS AND REVIEW OF THE COMPANY
The report sets out activities and achievements of the charity for 2024/2025. The organisation was formed in
September 1990 and founded as a charity in 1996. The objects of the charity allow the trustees to develop
comprehensively and consistently high quality services for users, their carers, families and professionals who
interact with them, within the Wolverhampton and surrounding areas notably Black Country and Staffordshire
The Trustees support a number of activities in pursuant of its objects. These are as follows:
•
To offer counselling and screening to those individuals affected by Sickle Cell or Thalassaemia.
To provide advice, support and guidance to affected individuals.
To increase awareness by developing educational materials and promotion of raising awareness
activities.
To support both universal and voluntary screening programmes
: To develop robust community development activities to promote and support the affected
communities.
• To strengthen and support families with complex and challenging needs.
The Trustees meet every three months to review overall performance of the charity and to give strategic
guidance. The directors/trustees review, and consider, the charitable company's reserves in the context of
risks and funding. In setting a reserves policy the directors aim to establish reasonable but not absolute
protection against risks and to balance this with the need to deploy resources in pursuit of the company's
charitable objectives. Reserves are intended to:
1) Provide protection for most fluctuations in income and expenditure
2) Fund future investment needs and non-recurrent premises costs
Operational Costs
With the changes that have taken place during the year it has necessitated a review of the Reserve Policy in
relation to operational activities. It is now proposed that the reserves target should at least cover eight months
Page 2

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2025
of operation including redundancy cost. The new proposed figure is E225,000. The Reserves at the end of the
financial year 2025 were £711,151 (2024: £733,112).
Rent Costs
SCTSP are currently residing in a building paying reduced service charge. This may not be a long-lasting
agreement and we cannot be certain in anyway shape or form that the management structure of the owners
of the building will not change and thereby begin to charge rent that will cause major disruption to the
operational activities of SCTSP. With this in mind it is our proposal that we begin to build a reserve in the
accounts to cater for this anomaly. We are currently paying service charge of about £9,750 per annum and we
would expect that we probably should be paying rent somewhere in the region of £28,000 per annum.
It is therefore proposed that in this year's accounts we set aside £48,000 in designated reserves.
The majority of the charitable company's funding is from NHS contracts which normally are renewable on a 1-
2 year period. Additional funding is obtained from donations by supporters of the charity, however given the
difficult economic climate, like many charities we have seen a reduction in this income, however we are still
appreciative of those who continue to collect donations on behalf of the charity. We also recognise that those
who make such donations are keen to see our service users directly benefit from their efforts and to this end
the Trustees have decided that the majority of these funds will go towards the Hardship Fund established by
the charity. Currently a provision of £5,000 has been set aside and will be drawn down within each year's
expenditure depending on numbers of individuals identified to receive such support.
The charity has invested surplus funds with the objective to generate funds through capital growth. The funds
are managed by Milsted Langdon and are monitored by the Finance Sub Committee with regular reports to
the Board. A cautious approach has been taken to risk over the period to reflect the volatility in the market
that can occur. With the increase in income the organisation will review its investment portfolio with this in
The Trustees regularly review the finances of the charity and are pleased that a satisfactory independent
accountant's examination has been achieved.
PUBLIC BENEFIT
All the charity's activities are aimed at supporting local individuals affected by sickle cell and thalassaemia and
families experiencing challenges. In developing activities and delivering services, the directors have taken
account of the guidance published by the Charity Commission on public benefit.
DEFINED BENEFIT PENSION SCHEME
A full actuarial valuation was carried out as at 31 March 2022, the results of which are shown in note 9 of the
financial statements. With respect to this liability Wolverhampton City Council has agreed to act as a guarantor
towards this liability. However, the recent actuarial valuation, which shows a current liability of £512,000; as
with previous years, the Trustees will continue to be mindful of this liability within its overall reserve policy.
RISK MANAGEMENT
The trustees have considered the major risks the charity faces. The charity's system of internal controls is
designed to provide reasonable but not absolute assurance against misstatement or loss. The trustees are
satisfied that the systems in place mitigate the charity's exposure to the major risks.
ON BEHALF OF THE BOARD:
mDel
C R Crosdale - Director/Trustee
Date: 23/9/2025
The notes form part of these financial statements
Page 3

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
STATEMENT OF TRUSTEES' RESPONSIBILITIES
FOR THE YEAR ENDED 31ST MARCH 2025
The trustees, who are also the directors of Sickle Cell and Thalassaemia Support Project (Wolverhampton) for
the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements
in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally
Accepted Accounting Practice).
Company Law requires the trustees to prepare financial statements for each financial year which give a true
and fair view of the state of affairs of the charity and of the incoming resources and application of resources,
including the income and expenditure, of the charitable company for that year.
In preparing these financial statements, the trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the Charities SORP;
- make judgements and estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards have been followed, subject to any material departures
disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the
charity will continue in operation.
The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy
at any time the financial position of the charity and enable them to ensure that the financial statements comply
with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence
for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The notes form part of these financial statements
Page 4

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
INDEPENDENT EXAMINER'S REPORT
FOR THE YEAR ENDED 31ST MARCH 2025
I report to the trustees on my examination of the financial statements of Sickle Cell And Thalassaemia Support
Project (Wolverhampton) (the charity) for the year ended 31 March 2025.
Responsibilities and basis of report
As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for
the preparation of the financial statements in accordance with the requirements of the Companies Act 2006
(the 2006 Act).
Having satisfied myself that the financial statements of the charity are not required to be audited under Part
16 of the 2006 Act and are eligible for independent examination, 1 report in respect of my examination of the
charity's financial statements carried out under the Charities Act (the Act). In carrying out my examination
have followed all the applicable Directions given by the Charity Commission under the Act
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the
examination giving me cause to believe that in any material respect:
1. accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act;
2
3
the financial statements do not accord with those records; or
the financial statements do not comply with the accounting requirements of section 396 of the 2006
Act other than any requirement that the accounts give a true and fair view which is not a matter
considered as part of an independent examination; or
4.
the financial statements have not been prepared in accordance with the methods and principles of the
Statement of Recommended Practice for accounting and reporting by charities applicable to charities
preparing their accounts in accordance with Section 1A "Small Entities" of Financial Reporting
Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".
I have no concerns and have come across no other matters in connection with the examination to which
attention should be drawn in this report in order to enable a proper understanding of the financial statements
to be reached.
Neil Harris FCA BSc (Hons)
Cygnet Accounting Limited
37 Rossell Drive
Stapleford
Nottingham
NG9 7EG
Dated:
21.02025•
The notes form part of these financial statements
Page 5

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 31ST MARCH 2025
Unrestricted Restricted
Funds
Funds
Notes
Total
Funds
2025
€
INCOME FROM:
Donations and other income
Investment income
Charitable activities:
Service level agreements from:
Black Country ICB Wolverhampton Place
Black Country ICB Dudley Place
Walsall Healthcare NHS Trust
TOTAL INCOME
EXPENDITURE ON:
Raising funds
Charitable activities
1
2
TOTAL EXPENDITURE
Net incoming / (expenditure) before gain or
loss on investments
Unrealised gain/(loss) on investments
Balances brought forward as at 1 April 2024
Balances carried forward as at 31 March 2025
50,164
26,735
76,899
300
7,243
7,543
69,356
1,872
535,143
606.371
:
50,164
26,735
116,414
17,065
51.142
184.621
116,414
17,065
51,142
261,520
13,086
264,724
277,810
(93,189)
13,386
271,967
285,353
(23,833)
-
197.969
104,780
1,872
733,112
711,151
Total
Funds
2024
90,001
18,593
115,720
16,962
50,773
292,049
10,981
230,534
241,515
50,534
4,317
678.261
733.112
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities
The statement of financial activities also complies with the requirements for an income and expenditure
account under the Companies Act 2006.
The notes form part of these financial statements
Page 6

1
2
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31ST MARCH 2025
Total
Unrestricted Restricted
Funds
Funds
Funds
2025
€
Total
Funds
2024
RAISING FUNDS
Wages
Social Security
Pensions
Repairs & maintenance
Telephone
Sundry expenses
Postage, printing & stationery
Rent & service charge
Insurance
Depreciation - office equipmen
Bank charge:
193
15
28
24
-
300
4
91
13,086
4
13,386
4
10.981
CHARITABLE ACTIVITIES
Wages
Social Security
Pensions
Staff training
Travelling
Repairs & maintenance
Social hardship donation
Social support
Consultancy service development
Subscriptions
Telephone
Sundry expenses
Postage, printing & stationery
Rent & service charge
Insurance
Depreciation - office equipment
Support costs:
Board expenses
Accountancy
Professional fees
1,832
283
537
-
75
182
811
-
-
2,180
128
143
153
179
66
20
77
573
7,243
181,406
13,854
26,331
300
1,434
3,463
1,245
-
6,266
2,713
2,899
8,770
3,238
68
382
1,473
10.882
264,724
183,238
14,137
26,868
300
1,509
3,645
811
-
1,245
2,180
6,394
2,856
3,052
8,949
3,304
72
1.000
11,455
271.967
85
230.534
The notes form part of these financial statements
Page 7

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
BALANCE SHEET
31ST MARCH 2025
2025
2024
Fixed assets
Tangible assets
Current assets
Debtors
Investments
Cash at bank and in hand
Creditors: Amounts falling
due within one year
Net current assets
Total assets less current
liabilities
Creditors: Amounts falling
due within one year
Net assets
Notes
4
€
428
7
12,910
54,796
729,567
797,273
(1,550)
795,723
796,151
8
85,000
711,151
€
€
504
7,190
52,924
760,334
820,448
(2,840)
817,608
818,112
85,000
733,112
Income funds
Unrestricted funds:
General funds
Designated funds
Restricted funds
Total income funds
526,371
80,000
606,371
104,780
711,151
455,143
80,000
535,143
197,969
733,112
The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year
ended 31st March 2025.
To decion export do at respond tea to mean in the regun al or ta mean it.
The members have not required the company to obtain an audit of its financial statements for the year ended
31st March 2025 in accordance with Section 476 of the Companies Act 2006.
These financial statements have been prepared in accordance with the provisions applicable to companies
subject to the small companies regime.
The financial statements were approved by the Board of Trustees on
.and
were signed on its behalf by:
c R Crosdale
Director/Trustee
Company registration number 03575079
Page 8

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
1.
Accounting policies
Charity information
Sickle Cell and Thalassaemia Support Project (Wolverhampton) is a private company limited by
guarantee incorporated in England and Wales. The registered office is Paycare House, 1st Floor,
George Street, Wolverhampton, WV2 4DX. The members of the company are the trustees names on
page 1. In the event of the charity being wound up, the liability in respect of the guarantee is limited to
£1 per member of the charity.
Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance
with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial
Reporting Standard applicable in the UK and Republic of Ireland", the Charities Act, the Companies Act
2006 and the Statement of Recommended Practice: "Accounting and Reporting by Charities" (FRS 102)
with the exception of accounting for the deficit on the defined benefit pension scheme, for which
provision has been made as set out below and in note 9.
The financial statements are prepared in sterling, which is the functional currency of the charity.
Monetary amounts in these financial statements are rounded to the nearest £.
Charitable funds
objectives.
Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable
Designated funds comprise unrestricted funds that have been set aside by the trustees for particular
purposes. The aim and use of each designated fund is set out in the notes to the financial statements.
Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes
and uses of the restricted funds are set out in the notes to the financial statements.
Income
Income is recognised when the charity is legally entitled to it after any performance conditions have
been met, the amounts can be measured reliably, and it is probable that income will be received.
Cash donations are recognised on receipt. Other donations are recognised once the charity has been
notified of the donation, unless performance conditions require deferral of the amount. Income tax
recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the
time of the donation.
Gifts in kind donated for distribution are included at valuation and recognised as income when they are
distributed to the projects. Gifts donated for resale are included as income when they are sold. Donated
facilities are included at the value to the charity where this can be quantified and a third party is bearing
the cost. No amounts are included in the financial statements for services donated by volunteers.
Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit
to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the
amount of the obligation can be measured reliably.
Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs
and shared costs, including support costs involved in undertaking each activity. Direct costs attributable
to a single activity are allocated directly to that activity. Shared costs which contribute to more than one
activity and support costs which are not attributable to a single activity are apportioned between those
activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis
of time spent, and depreciation charges are allocated on the portion of the asset's use.
Page 9

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
1. Accounting policies (continued)
All expenditure is accounted for on an accruals basis and has been classified under headings that
aggregate all costs related to the category. Where costs cannot by directly attributed to particular
headings they have been allocated to activities on a basis consistent with use of the resources.
Fund-raising costs are those incurred in seeking voluntary contributions and do not include the costs of
disseminating information in support of the charitable activities. Support costs are costs incurred directly
in support of expenditure on the objects of the charity and include project management carried out at
headquarters. Management and administration costs are those incurred in connection with the
administration of the charity and compliance with constitutional and statutory requirements.
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation,
net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values
over their useful lives on the following bases:
Plant and machinery
Fixtures and fittings
- 25% on cost
- 15% & 25% on reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale
proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.
Investments
Investments are stated at market value at the balance sheet date. The SOFA includes the net gains or
losses arising on revaluation throughout the year.
Pensions
The company operates a defined benefit pension scheme which provides benefits based on final
pensionable pay. The scheme is administered by the West Midlands Pension Fund, and the assets are
held independently of the finances of the company. The most recent full actuarial valuation was carried
out at 31 March 2022. The projected valuation deficit in the scheme at 31 March 2022 was E512,000
the Board has considered this situation and feels that because of the age of the work force this deficit
can be eliminated over a period of time and currently a total provision of £85,000 has been made to
date in these accounts.
Restricted Funds
Monies received as grants for particular purposes are held as separate funds and are credited to the
Statement of Financial Activities when costs of the particular relevant projects are incurred.
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to income
on a straight line basis over the term of the relevant lease.
Page 10

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
2.
STAFF COSTS
Wages and salaries
Social security costs
Other pension costs
2025
€
192,882
14,881
28,282
236,045
The average monthly number of employees during the year was as follows:
2025
2024
156,890
9,663
23.724
190,277
2024
Charitable Workers
ne employee (2024: nil) received total emoluments of more than £60,000 but less than £70,000. N
mployees (2024: nil) received total emoluments above £70,000
OPERATING PROFIT/(LOSS)
2024
Depreciation - owned assets
Directors' emoluments and other benefits etc
76
-
89
4.
TANGIBLE FIXED ASSETS
Cost
At 1st April 2024
Additions
Disposals
At 31st March 2025
epreciatio
t 1st April 202
Charge for year
Eliminated on disposals
At 31st March 2025
Net book value
At 31st March 2025
At 31st March 2024
Plant and
machinery
€
23,824
23,824
23,824
23,824
Fixtures and
fittings
13,391
13,391
12,887
76
12,963
428
504
Total
€
37.215
37,215
36,711
76
36,787
428
504
Page 11

5.
6.
8.
9.
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
DEBTORS: AMOUNTS FALLING
DUE WITHIN ONE YEAR
Prepayments and accrued income
2025
€
12,910
2024
7,190
CURRENT ASSET INVESTMENTS
Architas MA Passive Moderate S Acc
2025
€
54,796
2024
52,924
CREDITORS: AMOUNTS FALLING
DUE WITHIN ONE YEAR
Social security and other tax
Accruals and deferred income
2025
€
1,550
1,550
2024
€
2840
2,840
CREDITORS: AMOUNTS FALLING
DUE AFTER MORE THAN ONE YEAR
Provision for defined pension scheme deficit (see note 9)
2025
85,000
2024
85,000
PENSION SCHEME
Value of scheme assets and liabilities
Market value of assets
Present value of scheme liabilities
Pension scheme deficit
2025
€
2024
820,000
820,000
(1,332,000) (1,332.000)
(512,000)
(512,000)
The above is based on a valuation at 31 March 2022. Provision of £85,000 has been made towards
the above deficit.
Page 12

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
10.
OPERATING LEASE COMMITMENTS
At the reporting end date the charity had outstanding commitments for future minimum lease payment.
under non-cancellable operating leases, which fall due as follows
2025
2024
Within one year
Between two and five years
11. ANALYSIS OF NET ASSETS BETWEEN FUNDS
Fixed
Assets
Unrestricted Funds:
eneral Fund
esignated Fund
Restricted Funds
428
428
Other
Net
Assets
526,371
80,000
606,371
104,352
710,723
Total
Net
Assets
526,371
80,000
606,371
104,780
711,151
12. RESTRICTED FUNDS
Fund
Black Country ICB
Wolverhampton Place
Purpose of Fund
Reason for Restriction
Support the antenatal and newborn screening Wolverhampton residents
programme and provide counselling and
support to those affected
Black Country ICE
Dudley Place
Support affected children with long term
Dudley residents only
conditions to manage their condition through
various social and community interventions
Valsall Healthcare NHS Trust Support the antenatal and newborn screeni
Walsall residents only
rogramme and provide counselling ar
support to those affected
Page 13

COMPANY REGISTERED NUMBER: 03575079 (England and Wales)
CHARITY REGISTERED NUMBER: 1077687
SICKLE CELL AND THALASSAEMIA SUPPORT
PROJECT (WOLVERHAMPTON)
REPORT OF THE DIRECTORS AND
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
Company Information
Report of the Directors and Trustees
Statement of Trustees' responsibilities
Independent examiner's report
Statement of financial activities
Balance sheet
Notes to the financial statements
Page
1
2
4
5

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MARCH 2025
DIRECTORS/TRUSTEES:
SECRETARY:
REGISTERED OFFICE:
C R Crosdale
D Mcintosh
A Mcintos!
Or D Kalri
L Bell
LT Mooruth
DC Smith
A A Ezomon
S Herian
Paycare House
1st Floor
George Street
Wolverhampton
WV2 4DX
03575079 (England and Wales)
REGISTERED NUMBER:
REGISTERED CHARITY
NUMBER:
INDEPENDENT EXAMINER:
BANKERS:
SOLICITORS:
1077687
Neil Harris FCA BSc (Hons)
Cygnet Accounting Limited
37 Rossell Driv
Nottingham, NG9 TEC
Lloyds Bank Plc
37 Queen Square
Wolverhampton
WV1 1TL
Wall James Chappell
15-23 Hagley Road
Stourbridge
DY8 1QW
Page 1

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2025
The directors, who are also trustees of the charity, present their report with the financial statements of the
company for the year ended 31st March 2025. The directors have adopted the provisions of the Statement of
Recommended Practice (SORP) "Accounting and Reporting by Charities" (FRS 102) in preparing the annual
report and financial statements.
PRINCIPAL ACTIVITIES
The principal charitable activities of the company in the year under review were those to provide relief of
poverty, sickness and distress, and enhancement of life, to those affected by the disorders Sickle Cell Disease
and Thalassaemia, living within the West Midlands and surrounding areas. Those so affected are
predominantly from African, Caribbean, Mediterranean and Asian communities. In 2016 the charity had
expanded its activities to include working with families with complex and multiple needs, in order to promote,
strengthen and improve their life chances.
DIRECTORS AND TRUSTEES
The directors and trustees during the year under review were:
C R Crosdale
D Mcintosh
DA Mcintosh
Dr D Kalra
L Bell
L T Mooruth
D C Smith
A A Ezomon
COMPANY STATUS
The company is limited by guarantee and is a registered charity (Registered No 1077687). This report has
been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to
small companies.
OBJECTS AND REVIEW OF THE COMPANY
The report sets out activities and achievements of the charity for 2024/2025. The organisation was formed in
September 1990 and founded as a charity in 1996. The objects of the charity allow the trustees to develop
comprehensively and consistently high quality services for users, their carers, families and professionals who
interact with them, within the Wolverhampton and surrounding areas notably Black Country and Staffordshire
The Trustees support a number of activities in pursuant of its objects. These are as follows:
•
To offer counselling and screening to those individuals affected by Sickle Cell or Thalassaemia.
To provide advice, support and guidance to affected individuals.
To increase awareness by developing educational materials and promotion of raising awareness
activities.
To support both universal and voluntary screening programmes
: To develop robust community development activities to promote and support the affected
communities.
• To strengthen and support families with complex and challenging needs.
The Trustees meet every three months to review overall performance of the charity and to give strategic
guidance. The directors/trustees review, and consider, the charitable company's reserves in the context of
risks and funding. In setting a reserves policy the directors aim to establish reasonable but not absolute
protection against risks and to balance this with the need to deploy resources in pursuit of the company's
charitable objectives. Reserves are intended to:
1) Provide protection for most fluctuations in income and expenditure
2) Fund future investment needs and non-recurrent premises costs
Operational Costs
With the changes that have taken place during the year it has necessitated a review of the Reserve Policy in
relation to operational activities. It is now proposed that the reserves target should at least cover eight months
Page 2

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
REPORT OF THE DIRECTORS AND TRUSTEES
FOR THE YEAR ENDED 31ST MARCH 2025
of operation including redundancy cost. The new proposed figure is E225,000. The Reserves at the end of the
financial year 2025 were £711,151 (2024: £733,112).
Rent Costs
SCTSP are currently residing in a building paying reduced service charge. This may not be a long-lasting
agreement and we cannot be certain in anyway shape or form that the management structure of the owners
of the building will not change and thereby begin to charge rent that will cause major disruption to the
operational activities of SCTSP. With this in mind it is our proposal that we begin to build a reserve in the
accounts to cater for this anomaly. We are currently paying service charge of about £9,750 per annum and we
would expect that we probably should be paying rent somewhere in the region of £28,000 per annum.
It is therefore proposed that in this year's accounts we set aside £48,000 in designated reserves.
The majority of the charitable company's funding is from NHS contracts which normally are renewable on a 1-
2 year period. Additional funding is obtained from donations by supporters of the charity, however given the
difficult economic climate, like many charities we have seen a reduction in this income, however we are still
appreciative of those who continue to collect donations on behalf of the charity. We also recognise that those
who make such donations are keen to see our service users directly benefit from their efforts and to this end
the Trustees have decided that the majority of these funds will go towards the Hardship Fund established by
the charity. Currently a provision of £5,000 has been set aside and will be drawn down within each year's
expenditure depending on numbers of individuals identified to receive such support.
The charity has invested surplus funds with the objective to generate funds through capital growth. The funds
are managed by Milsted Langdon and are monitored by the Finance Sub Committee with regular reports to
the Board. A cautious approach has been taken to risk over the period to reflect the volatility in the market
that can occur. With the increase in income the organisation will review its investment portfolio with this in
The Trustees regularly review the finances of the charity and are pleased that a satisfactory independent
accountant's examination has been achieved.
PUBLIC BENEFIT
All the charity's activities are aimed at supporting local individuals affected by sickle cell and thalassaemia and
families experiencing challenges. In developing activities and delivering services, the directors have taken
account of the guidance published by the Charity Commission on public benefit.
DEFINED BENEFIT PENSION SCHEME
A full actuarial valuation was carried out as at 31 March 2022, the results of which are shown in note 9 of the
financial statements. With respect to this liability Wolverhampton City Council has agreed to act as a guarantor
towards this liability. However, the recent actuarial valuation, which shows a current liability of £512,000; as
with previous years, the Trustees will continue to be mindful of this liability within its overall reserve policy.
RISK MANAGEMENT
The trustees have considered the major risks the charity faces. The charity's system of internal controls is
designed to provide reasonable but not absolute assurance against misstatement or loss. The trustees are
satisfied that the systems in place mitigate the charity's exposure to the major risks.
ON BEHALF OF THE BOARD:
mDel
C R Crosdale - Director/Trustee
Date: 23/9/2025
The notes form part of these financial statements
Page 3

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
STATEMENT OF TRUSTEES' RESPONSIBILITIES
FOR THE YEAR ENDED 31ST MARCH 2025
The trustees, who are also the directors of Sickle Cell and Thalassaemia Support Project (Wolverhampton) for
the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements
in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally
Accepted Accounting Practice).
Company Law requires the trustees to prepare financial statements for each financial year which give a true
and fair view of the state of affairs of the charity and of the incoming resources and application of resources,
including the income and expenditure, of the charitable company for that year.
In preparing these financial statements, the trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the Charities SORP;
- make judgements and estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards have been followed, subject to any material departures
disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the
charity will continue in operation.
The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy
at any time the financial position of the charity and enable them to ensure that the financial statements comply
with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence
for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The notes form part of these financial statements
Page 4

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
INDEPENDENT EXAMINER'S REPORT
FOR THE YEAR ENDED 31ST MARCH 2025
I report to the trustees on my examination of the financial statements of Sickle Cell And Thalassaemia Support
Project (Wolverhampton) (the charity) for the year ended 31 March 2025.
Responsibilities and basis of report
As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for
the preparation of the financial statements in accordance with the requirements of the Companies Act 2006
(the 2006 Act).
Having satisfied myself that the financial statements of the charity are not required to be audited under Part
16 of the 2006 Act and are eligible for independent examination, 1 report in respect of my examination of the
charity's financial statements carried out under the Charities Act (the Act). In carrying out my examination
have followed all the applicable Directions given by the Charity Commission under the Act
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the
examination giving me cause to believe that in any material respect:
1. accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act;
2
3
the financial statements do not accord with those records; or
the financial statements do not comply with the accounting requirements of section 396 of the 2006
Act other than any requirement that the accounts give a true and fair view which is not a matter
considered as part of an independent examination; or
4.
the financial statements have not been prepared in accordance with the methods and principles of the
Statement of Recommended Practice for accounting and reporting by charities applicable to charities
preparing their accounts in accordance with Section 1A "Small Entities" of Financial Reporting
Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland".
I have no concerns and have come across no other matters in connection with the examination to which
attention should be drawn in this report in order to enable a proper understanding of the financial statements
to be reached.
Neil Harris FCA BSc (Hons)
Cygnet Accounting Limited
37 Rossell Drive
Stapleford
Nottingham
NG9 7EG
Dated:
21.02025•
The notes form part of these financial statements
Page 5

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME AND EXPENDITURE ACCOUNT)
FOR THE YEAR ENDED 31ST MARCH 2025
Unrestricted Restricted
Funds
Funds
Notes
Total
Funds
2025
€
INCOME FROM:
Donations and other income
Investment income
Charitable activities:
Service level agreements from:
Black Country ICB Wolverhampton Place
Black Country ICB Dudley Place
Walsall Healthcare NHS Trust
TOTAL INCOME
EXPENDITURE ON:
Raising funds
Charitable activities
1
2
TOTAL EXPENDITURE
Net incoming / (expenditure) before gain or
loss on investments
Unrealised gain/(loss) on investments
Balances brought forward as at 1 April 2024
Balances carried forward as at 31 March 2025
50,164
26,735
76,899
300
7,243
7,543
69,356
1,872
535,143
606.371
:
50,164
26,735
116,414
17,065
51.142
184.621
116,414
17,065
51,142
261,520
13,086
264,724
277,810
(93,189)
13,386
271,967
285,353
(23,833)
-
197.969
104,780
1,872
733,112
711,151
Total
Funds
2024
90,001
18,593
115,720
16,962
50,773
292,049
10,981
230,534
241,515
50,534
4,317
678.261
733.112
The statement of financial activities includes all gains and losses recognised in the year.
All income and expenditure derive from continuing activities
The statement of financial activities also complies with the requirements for an income and expenditure
account under the Companies Act 2006.
The notes form part of these financial statements
Page 6

1
2
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEAR ENDED 31ST MARCH 2025
Total
Unrestricted Restricted
Funds
Funds
Funds
2025
€
Total
Funds
2024
RAISING FUNDS
Wages
Social Security
Pensions
Repairs & maintenance
Telephone
Sundry expenses
Postage, printing & stationery
Rent & service charge
Insurance
Depreciation - office equipmen
Bank charge:
193
15
28
24
-
300
4
91
13,086
4
13,386
4
10.981
CHARITABLE ACTIVITIES
Wages
Social Security
Pensions
Staff training
Travelling
Repairs & maintenance
Social hardship donation
Social support
Consultancy service development
Subscriptions
Telephone
Sundry expenses
Postage, printing & stationery
Rent & service charge
Insurance
Depreciation - office equipment
Support costs:
Board expenses
Accountancy
Professional fees
1,832
283
537
-
75
182
811
-
-
2,180
128
143
153
179
66
20
77
573
7,243
181,406
13,854
26,331
300
1,434
3,463
1,245
-
6,266
2,713
2,899
8,770
3,238
68
382
1,473
10.882
264,724
183,238
14,137
26,868
300
1,509
3,645
811
-
1,245
2,180
6,394
2,856
3,052
8,949
3,304
72
1.000
11,455
271.967
85
230.534
The notes form part of these financial statements
Page 7

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
BALANCE SHEET
31ST MARCH 2025
2025
2024
Fixed assets
Tangible assets
Current assets
Debtors
Investments
Cash at bank and in hand
Creditors: Amounts falling
due within one year
Net current assets
Total assets less current
liabilities
Creditors: Amounts falling
due within one year
Net assets
Notes
4
€
428
7
12,910
54,796
729,567
797,273
(1,550)
795,723
796,151
8
85,000
711,151
€
€
504
7,190
52,924
760,334
820,448
(2,840)
817,608
818,112
85,000
733,112
Income funds
Unrestricted funds:
General funds
Designated funds
Restricted funds
Total income funds
526,371
80,000
606,371
104,780
711,151
455,143
80,000
535,143
197,969
733,112
The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year
ended 31st March 2025.
To decion export do at respond tea to mean in the regun al or ta mean it.
The members have not required the company to obtain an audit of its financial statements for the year ended
31st March 2025 in accordance with Section 476 of the Companies Act 2006.
These financial statements have been prepared in accordance with the provisions applicable to companies
subject to the small companies regime.
The financial statements were approved by the Board of Trustees on
.and
were signed on its behalf by:
c R Crosdale
Director/Trustee
Company registration number 03575079
Page 8

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
1.
Accounting policies
Charity information
Sickle Cell and Thalassaemia Support Project (Wolverhampton) is a private company limited by
guarantee incorporated in England and Wales. The registered office is Paycare House, 1st Floor,
George Street, Wolverhampton, WV2 4DX. The members of the company are the trustees names on
page 1. In the event of the charity being wound up, the liability in respect of the guarantee is limited to
£1 per member of the charity.
Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance
with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial
Reporting Standard applicable in the UK and Republic of Ireland", the Charities Act, the Companies Act
2006 and the Statement of Recommended Practice: "Accounting and Reporting by Charities" (FRS 102)
with the exception of accounting for the deficit on the defined benefit pension scheme, for which
provision has been made as set out below and in note 9.
The financial statements are prepared in sterling, which is the functional currency of the charity.
Monetary amounts in these financial statements are rounded to the nearest £.
Charitable funds
objectives.
Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable
Designated funds comprise unrestricted funds that have been set aside by the trustees for particular
purposes. The aim and use of each designated fund is set out in the notes to the financial statements.
Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes
and uses of the restricted funds are set out in the notes to the financial statements.
Income
Income is recognised when the charity is legally entitled to it after any performance conditions have
been met, the amounts can be measured reliably, and it is probable that income will be received.
Cash donations are recognised on receipt. Other donations are recognised once the charity has been
notified of the donation, unless performance conditions require deferral of the amount. Income tax
recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the
time of the donation.
Gifts in kind donated for distribution are included at valuation and recognised as income when they are
distributed to the projects. Gifts donated for resale are included as income when they are sold. Donated
facilities are included at the value to the charity where this can be quantified and a third party is bearing
the cost. No amounts are included in the financial statements for services donated by volunteers.
Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit
to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the
amount of the obligation can be measured reliably.
Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs
and shared costs, including support costs involved in undertaking each activity. Direct costs attributable
to a single activity are allocated directly to that activity. Shared costs which contribute to more than one
activity and support costs which are not attributable to a single activity are apportioned between those
activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis
of time spent, and depreciation charges are allocated on the portion of the asset's use.
Page 9

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
1. Accounting policies (continued)
All expenditure is accounted for on an accruals basis and has been classified under headings that
aggregate all costs related to the category. Where costs cannot by directly attributed to particular
headings they have been allocated to activities on a basis consistent with use of the resources.
Fund-raising costs are those incurred in seeking voluntary contributions and do not include the costs of
disseminating information in support of the charitable activities. Support costs are costs incurred directly
in support of expenditure on the objects of the charity and include project management carried out at
headquarters. Management and administration costs are those incurred in connection with the
administration of the charity and compliance with constitutional and statutory requirements.
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation,
net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values
over their useful lives on the following bases:
Plant and machinery
Fixtures and fittings
- 25% on cost
- 15% & 25% on reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale
proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.
Investments
Investments are stated at market value at the balance sheet date. The SOFA includes the net gains or
losses arising on revaluation throughout the year.
Pensions
The company operates a defined benefit pension scheme which provides benefits based on final
pensionable pay. The scheme is administered by the West Midlands Pension Fund, and the assets are
held independently of the finances of the company. The most recent full actuarial valuation was carried
out at 31 March 2022. The projected valuation deficit in the scheme at 31 March 2022 was E512,000
the Board has considered this situation and feels that because of the age of the work force this deficit
can be eliminated over a period of time and currently a total provision of £85,000 has been made to
date in these accounts.
Restricted Funds
Monies received as grants for particular purposes are held as separate funds and are credited to the
Statement of Financial Activities when costs of the particular relevant projects are incurred.
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to income
on a straight line basis over the term of the relevant lease.
Page 10

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
2.
STAFF COSTS
Wages and salaries
Social security costs
Other pension costs
2025
€
192,882
14,881
28,282
236,045
The average monthly number of employees during the year was as follows:
2025
2024
156,890
9,663
23.724
190,277
2024
Charitable Workers
ne employee (2024: nil) received total emoluments of more than £60,000 but less than £70,000. N
mployees (2024: nil) received total emoluments above £70,000
OPERATING PROFIT/(LOSS)
2024
Depreciation - owned assets
Directors' emoluments and other benefits etc
76
-
89
4.
TANGIBLE FIXED ASSETS
Cost
At 1st April 2024
Additions
Disposals
At 31st March 2025
epreciatio
t 1st April 202
Charge for year
Eliminated on disposals
At 31st March 2025
Net book value
At 31st March 2025
At 31st March 2024
Plant and
machinery
€
23,824
23,824
23,824
23,824
Fixtures and
fittings
13,391
13,391
12,887
76
12,963
428
504
Total
€
37.215
37,215
36,711
76
36,787
428
504
Page 11

5.
6.
8.
9.
SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
DEBTORS: AMOUNTS FALLING
DUE WITHIN ONE YEAR
Prepayments and accrued income
2025
€
12,910
2024
7,190
CURRENT ASSET INVESTMENTS
Architas MA Passive Moderate S Acc
2025
€
54,796
2024
52,924
CREDITORS: AMOUNTS FALLING
DUE WITHIN ONE YEAR
Social security and other tax
Accruals and deferred income
2025
€
1,550
1,550
2024
€
2840
2,840
CREDITORS: AMOUNTS FALLING
DUE AFTER MORE THAN ONE YEAR
Provision for defined pension scheme deficit (see note 9)
2025
85,000
2024
85,000
PENSION SCHEME
Value of scheme assets and liabilities
Market value of assets
Present value of scheme liabilities
Pension scheme deficit
2025
€
2024
820,000
820,000
(1,332,000) (1,332.000)
(512,000)
(512,000)
The above is based on a valuation at 31 March 2022. Provision of £85,000 has been made towards
the above deficit.
Page 12

SICKLE CELL AND THALASSAEMIA SUPPORT PROJECT (WOLVERHAMPTON)
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2025
10.
OPERATING LEASE COMMITMENTS
At the reporting end date the charity had outstanding commitments for future minimum lease payment.
under non-cancellable operating leases, which fall due as follows
2025
2024
Within one year
Between two and five years
11. ANALYSIS OF NET ASSETS BETWEEN FUNDS
Fixed
Assets
Unrestricted Funds:
eneral Fund
esignated Fund
Restricted Funds
428
428
Other
Net
Assets
526,371
80,000
606,371
104,352
710,723
Total
Net
Assets
526,371
80,000
606,371
104,780
711,151
12. RESTRICTED FUNDS
Fund
Black Country ICB
Wolverhampton Place
Purpose of Fund
Reason for Restriction
Support the antenatal and newborn screening Wolverhampton residents
programme and provide counselling and
support to those affected
Black Country ICE
Dudley Place
Support affected children with long term
Dudley residents only
conditions to manage their condition through
various social and community interventions
Valsall Healthcare NHS Trust Support the antenatal and newborn screeni
Walsall residents only
rogramme and provide counselling ar
support to those affected
Page 13